Latest3rd-party tested
99.85%
Purity
- Product
- SEMAX
SEMAX
Compound Research · 10mg
Size: 10mg
$75.00$52.5030% OFF
With code FALL
30% off sitewide with code FALL — apply it in your cart
Semax is a synthetic peptide analog derived from adrenocorticotropic hormone (ACTH 4–10), supplied for laboratory research. It is widely studied in research settings for its interactions with neurochemical signaling pathways, cognitive-related mechanisms, and stress-response systems.
For Research Use Only. Not for human or veterinary use.
Research Use Notes
Supplied as lyophilized powder
Requires reconstitution before use
Research Water required for mixing (sold separately)
Swirl gently, never shake
Storage
Store lyophilized powder vial in freezer
Keep at 2 to 8°C
Protect from light and heat
After mixing, keep refrigerated
Use within typical research handling window after reconstitution
Handling
Use sterile technique during reconstitution
For laboratory research use only
Certificate of Analysis
Every batch is independently third-party tested before it ships. Open a certificate to see the full lab report.
All certificates are issued by independent laboratories. Lot-specific documents are available to qualified research professionals on request.
Frequently Bought Together
Commonly paired to support consistent, reliable experimentation.
Compound Information
Technical specifications
Product Details
What Is SEMAX?
Compound Research · 10mg
- SKU
- 011
- Category
- Compounds, Neuro Research
- Strength
- 10MG
- Purity
- 99%+
- Form
- Lyophilized powder
- Sizes
- 10mg
Storage Requirements
Stability Information
Avoid freeze/thaw cyclesProtect from lightKeep refrigerated
Lyophilized (powder)
-20°C
24+ months
Reconstituted
2-8°C
~30 days
For Research Use Only
Products are intended solely for laboratory and scientific research purposes. Not intended for human consumption, veterinary use, diagnosis, treatment, cure, or prevention of disease.
All the research compounds you need, with the confidence that every batch is 7× tested before it ships.
Subscribe to our Newsletter
Subscribe to our newsletter to get daily insights, news, updates.